Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionality is currently unavailable.

Kimberly Perez, M.D.

Concepts (70)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Somatostatin120194390.760 Why?
Pancreatic Neoplasms6201943400.750 Why?
Intestinal Neoplasms120193110.740 Why?
Neuroendocrine Tumors120194850.620 Why?
Adenocarcinoma4201862060.520 Why?
Stomach Neoplasms1201911260.480 Why?
Rectal Neoplasms120178930.450 Why?
Antineoplastic Combined Chemotherapy Protocols3201797990.380 Why?
Leucovorin320175340.370 Why?
Organoplatinum Compounds320174760.350 Why?
Fluorouracil3201715610.280 Why?
Jews120193500.190 Why?
Antineoplastic Agents12019131270.170 Why?
Review Literature as Topic120162670.160 Why?
Medical History Taking120197590.150 Why?
Preoperative Period120164920.150 Why?
Digestive System Surgical Procedures120175040.130 Why?
Genomics2201841900.130 Why?
Radiotherapy, Intensity-Modulated120177010.120 Why?
Genetic Variation2201861950.120 Why?
Drug Administration Schedule2201751020.120 Why?
Radiopharmaceuticals1201924910.110 Why?
Carcinoma, Pancreatic Ductal1201811240.110 Why?
Lymphatic Metastasis1201729690.100 Why?
Chemotherapy, Adjuvant1201731770.100 Why?
Neoadjuvant Therapy1201718660.100 Why?
High-Throughput Nucleotide Sequencing2201829200.090 Why?
Neoplasm Staging22017105020.080 Why?
Neoplasm Proteins1201837010.080 Why?
Gene Expression Profiling2201892900.070 Why?
Treatment Outcome32019552240.070 Why?
Prognosis22019261260.060 Why?
Germ-Line Mutation2201814010.060 Why?
Middle Aged720191999930.060 Why?
Clinical Trials as Topic1201675880.050 Why?
Practice Guidelines as Topic1201670620.050 Why?
Aged620191473540.040 Why?
Genetic Predisposition to Disease12018156090.040 Why?
Disease-Free Survival2201869700.040 Why?
Humans820196133770.040 Why?
Female620193447160.040 Why?
Albumins120165000.040 Why?
Maximum Tolerated Dose120168700.040 Why?
DNA Breaks, Double-Stranded120185470.040 Why?
Cancer Care Facilities120163930.030 Why?
Infusions, Intravenous1201622930.030 Why?
Sequence Analysis, RNA1201816490.030 Why?
MAP Kinase Signaling System1201815530.030 Why?
Gene Regulatory Networks1201814930.030 Why?
Male520193262520.030 Why?
Paclitaxel1201615340.030 Why?
Neoplasms12016167570.030 Why?
DNA Repair1201819400.020 Why?
Neoplasm Invasiveness1201636740.020 Why?
Ethnic Groups1201829280.020 Why?
Kaplan-Meier Estimate1201666760.020 Why?
Molecular Targeted Therapy1201625760.020 Why?
Adult420181950380.020 Why?
Patient Selection1201641630.020 Why?
Dose-Response Relationship, Drug12016116360.020 Why?
Survival Analysis12016102710.020 Why?
Gene Expression Regulation, Neoplastic1201880570.020 Why?
Aged, 80 and over22018543420.020 Why?
Genotype12016126490.010 Why?
Colorectal Neoplasms1201955630.010 Why?
Risk Assessment12016213750.010 Why?
Prospective Studies12016437510.010 Why?
Breast Neoplasms12019179640.010 Why?
Risk Factors12019634600.010 Why?
United States12016576400.010 Why?
Perez's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (70)
Explore
_
Co-Authors (43)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.